Proton-pump inhibitors are associated with a reduced risk for bleeding and perforated gastroduodenal ulcers attributable to non-steroidal anti-inflammatory drugs: a nested case-control study
about
Decreasing incidence of peptic ulcer complications after the introduction of the proton pump inhibitors, a study of the Swedish population from 1974-2002.The proton-pump inhibitor lansoprazole enhances amyloid beta production.Systematic review with network meta-analysis: comparative effectiveness and safety of strategies for preventing NSAID-associated gastrointestinal toxicity.Tramadol/paracetamol fixed-dose combination in the treatment of moderate to severe pain.Proton pump inhibitors for preventing non-steroidal anti-inflammatory drug induced gastrointestinal toxicity: a systematic review.Gastrointestinal toxicity among patients taking selective COX-2 inhibitors or conventional NSAIDs, alone or combined with proton pump inhibitors: a case-control study.Incremental cost effectiveness of proton pump inhibitors for the prevention of non-steroidal anti-inflammatory drug ulcers: a pharmacoeconomic analysis linked to a case-control study.Non-steroidal anti-inflammatory drugs and gastroprotection with proton pump inhibitors: a focus on ketoprofen/omeprazole.Upper gastrointestinal bleeding associated with NSAIDs, other drugs and interactions: a nested case-control study in a new general practice database.Strategies to improve the outcome of emergency surgery for perforated peptic ulcer.Safety and tolerability of high-dose intravenous esomeprazole for prevention of peptic ulcer rebleeding.Evidence-based clinical practice guidelines for peptic ulcer disease 2015.Beta-cyclodextrin enhanced gastroprotective effect of (-)-linalool, a monoterpene present in rosewood essential oil, in gastric lesion models.Efficacy and safety of a fixed-dose combination of nimesulide/pantoprazole compared to naproxen/esomeprazole for pain relief in patients with osteoarticular diseases and dyspeptic symptoms
P2860
Q33432343-29CFBAB9-D988-4549-A632-69C9E4E48395Q34631939-DD48ADDA-D7DB-4C24-8A4B-39A7DC077D4DQ36001198-9C2F83C6-5B27-45DA-A09D-73F4FBFA61CAQ36235082-C8E7A392-96E6-44E2-A8DB-12B25C771F02Q36246550-009476AE-6E59-40CE-9107-F9DC553E392AQ36332697-99945160-EB31-46CF-A1E2-64F6A021E936Q37129605-047AF48F-850A-46E0-875F-A474286E758BQ37986562-8B0F013B-64B5-45DF-93A8-429DB3CB2BD3Q38041462-A1ED3AB9-5C3B-4C0A-854F-876A1B8155C3Q38171407-F285E05B-3867-4A1A-829E-EFB564A40FC5Q38496549-9027E1A6-5FAE-48E0-8602-25D29A4C2CDCQ40790399-029DE1FB-4D62-4F21-A7A7-7EBE6B33F4DCQ52857458-53F29F40-5026-4452-8D66-1F7171282B66Q58761617-276C9020-53CB-45F9-AD01-C7F92AF1A156
P2860
Proton-pump inhibitors are associated with a reduced risk for bleeding and perforated gastroduodenal ulcers attributable to non-steroidal anti-inflammatory drugs: a nested case-control study
description
2007 nî lūn-bûn
@nan
2007 թուականին հրատարակուած գիտական յօդուած
@hyw
2007 թվականին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Proton-pump inhibitors are ass ...... s: a nested case-control study
@ast
Proton-pump inhibitors are ass ...... s: a nested case-control study
@en
Proton-pump inhibitors are ass ...... s: a nested case-control study
@nl
type
label
Proton-pump inhibitors are ass ...... s: a nested case-control study
@ast
Proton-pump inhibitors are ass ...... s: a nested case-control study
@en
Proton-pump inhibitors are ass ...... s: a nested case-control study
@nl
prefLabel
Proton-pump inhibitors are ass ...... s: a nested case-control study
@ast
Proton-pump inhibitors are ass ...... s: a nested case-control study
@en
Proton-pump inhibitors are ass ...... s: a nested case-control study
@nl
P2093
P2860
P356
P1476
Proton-pump inhibitors are ass ...... s: a nested case-control study
@en
P2093
Eric N van Roon
Harald E Vonkeman
Mart A F J van de Laar
Robert W Fernandes
P2860
P2888
P356
10.1186/AR2207
P407
P577
2007-01-01T00:00:00Z